CRISPR Therapeutics Stock Near 5-Year Lows—But Gene Editing’s Future Is Just Begin
CRISPR Therapeutics AG · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $56.18
+18% in 7d after detection
Post-detection moves
1h
—
1d
+2.0%
3d
+5.8%
7d
+18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS